WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009140448) TETRAHYDROCYCLOPENTA[B]INDOLE ANDROGEN RECEPTOR MODULATORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/140448    International Application No.:    PCT/US2009/043875
Publication Date: 19.11.2009 International Filing Date: 14.05.2009
IPC:
C07D 209/94 (2006.01), C07D 401/06 (2006.01), C07D 403/06 (2006.01), A61K 31/403 (2006.01), A61K 31/4439 (2006.01), A61P 5/26 (2006.01), A61P 19/10 (2006.01), A61P 21/00 (2006.01)
Applicants: ELI LILLY AND COMPANY [US/US]; Lilly Corporate Center Indianapolis, IN 46285 (US) (For All Designated States Except US).
JADHAV, Prabhakar, Kondaji [US/US]; (US) (For US Only).
KRISHNAN, Venkatesh [US/US]; (US) (For US Only).
KIM, Euibong, Jemes [US/US]; (US) (For US Only)
Inventors: JADHAV, Prabhakar, Kondaji; (US).
KRISHNAN, Venkatesh; (US).
KIM, Euibong, Jemes; (US)
Agent: WILSON, Alexander; (US)
Priority Data:
61/053,722 16.05.2008 US
Title (EN) TETRAHYDROCYCLOPENTA[B]INDOLE ANDROGEN RECEPTOR MODULATORS
(FR) MODULATEURS DES RÉCEPTEURS AUX ANDROGÈNES TÉTRAHYDROCYCLOPENTA[B]INDOLES
Abstract: front page image
(EN)The present invention provides a compound of the Formula (I), or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating or preventing physiological disorders, particularly reduced bone mass, osteoporosis, osteopenia, reduced muscle mass or strength, or erectile dysfunction comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
(FR)La présente invention porte sur un composé de la formule : Formule (I), ou un sel pharmaceutiquement acceptable de celui-ci; sur des compositions pharmaceutiques comprenant un composé de Formule (I) en combinaison avec un support, diluant ou excipient approprié; et sur des procédés pour traiter ou prévenir des troubles physiologiques, en particulier une masse osseuse réduite, l'ostéoporose, l'ostéopénie, une masse ou force musculaire réduite ou un dysfonctionnement érectile, comprenant l'administration d'un composé de Formule (I) ou d'un sel pharmaceutiquement acceptable de celui-ci.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)